5.2900.00% ( 0.000 )
Closed: Nov 10, 09:20:00 (EDT)Current ValuationThe current P/E ratio is 13.07, within the reasonable range, cheaper than 45.21% of the time in the past 1 years, and the industry ranks 6/53, the industry Median -0.10.
13.07xP/E
$5.29Stock price
$0.40Earnings per share
13.07xP/E
Stock price$5.29Earnings per share$0.40
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 11.30x
- Typical range
- 7.78x–14.82x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0285684112
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
ULUSUnilever | 13.51x | 14.12% | $145.26B |
BDRFYUSBeiersdorf | 19.04x | -- | $20.71B |
NATRUSNatures Sunshine | 13.03x | 26.42% | $190.96M |
NAGEUSNiagen Bioscience | 17.62x | 77.50% | $180.41M |
FTLFUSFitLife Brands | 12.39x | 37.30% | $77.19M |
LFVNUSLifevantage | 13.07x | 51.25% | $66.27M |
UGUSUnited-Guardian | 16.49x | -- | $40.66M |
AXILUSAXIL Brands | 13.27x | 48.48% | $36.98M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
